Wall Street sets XPeng stock price for the next 12 months

Goldman Sachs reiterated its Buy rating on XPeng but cut its 12-month price target 33%, from $24 to $16, while still implying about 75% upside from the article’s reference price. XPeng rose 4% in pre-market trading to $9.44, but shares were down 11.85% over 30 days and 55.6% year to date; TipRanks’ $17.21 average target implies about 89% upside. Analysts cite potential in XPeng’s physical-AI ambitions, while investors remain concerned about spending, cash burn, overseas tariffs and weak China demand.

Analysis

The target reset matters more than the Buy label: it signals that even a constructive analyst case is being repriced against execution and funding risk. At the stated sales multiple, Xpeng is not a conventional deep-value auto exposure; investors are paying for technology optionality, so weak vehicle demand or continued investment without measurable monetization can compress the multiple toward auto-sector levels before any balance-sheet stress is established.

Near term, the pre-market bounce may be positioning around analyst commentary rather than a change in fundamentals. Over the next 1–3 months, watch deliveries, pricing/incentives, cash consumption, and guidance for AI/robotics investment; these determine whether the market treats the strategy as funded option value or a drag on returns. Over 6–18 months, successful commercialization could support a rerating, but tariffs and China demand remain independent constraints on vehicle economics. A useful relative lens is whether Xpeng can show better execution than peers such as Li Auto and Nio, not simply whether the physical-AI narrative attracts attention.

Contrarian point: the sharp share-price decline may already discount substantial disappointment, but a low sales multiple alone is not a floor when the premium over autos depends on unproven conversion of spending into revenue and cash generation. The bullish case is falsified by deteriorating delivery/pricing trends or worsening cash metrics without evidence of commercialization; sustained operating improvement and credible monetization would undermine the bearish case.

Key Decisions for Investors

• Do not chase the headline-driven bounce. Keep XPEV on a catalyst watchlist and require evidence in deliveries, pricing, cash use, and guidance before adding fundamental exposure.
• For investors seeking downside exposure, consider a defined-risk XPEV put spread rather than an outright short, subject to option liquidity and implied-volatility pricing. Reassess if operating metrics stabilize or commercialization evidence emerges; avoid the trade if option premiums already price severe downside.
• A relative-value short against Li Auto or Nio is not yet justified from the supplied information alone. Compare delivery growth, pricing, cash burn, and valuation on consistent periods before expressing that view.
• Set a positive-thesis trigger around improving vehicle execution plus verifiable AI/robotics monetization; treat persistent demand weakness, worsening cash metrics, or adverse tariff developments as thesis-invalidating for a long.